Mobilee® (High-Molecular-Weight Oral Hyaluronic Acid Complex)

Evidence Level
Moderate
2 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

Mobilee® is a Bioiberica-developed oral joint-health ingredient combining high-molecular-weight hyaluronic acid (≈60-70%) with polysaccharides and a collagen-stimulating fraction, derived from rooster comb extract. Distinct from generic oral hyaluronic acid, Mobilee® has been studied in randomized human trials in adults with mild knee discomfort, both delivered in a low-fat yoghurt: a 12-week trial reporting improved knee muscle strength in men only, and a 90-day trial (68 completers) reporting reduced knee pain and synovial effusion, with a transcriptomics substudy. The trial program is industry-supported and the evidence base is modest; positioning is best framed as joint-comfort and muscle-joint function support rather than as a disease-modifying intervention.

Studied Dose ~80 mg/day rooster comb extract (about 50 mg hyaluronic acid/day) for 12 weeks (Sola) and 90 days (Sanchez); both cited trials delivered it in a low-fat yoghurt.
Active Compound Rooster comb-derived extract standardized for high-molecular-weight hyaluronic acid (≈60-70%) plus polysaccharides and a collagen-stimulating fraction; branded as Mobilee® by Bioiberica.

Benefits

Supports joint comfort in adults with mild knee discomfort

A 90-day industry RCT (68 completers) reported reduced knee pain intensity and synovial effusion versus placebo yoghurt. The separate 12-week trial measured knee muscle strength, not pain. Both are industry (Bioiberica) yoghurt studies from the same research program with no independent replication, so the joint-comfort evidence is modest.

May support knee muscle strength (men only in one trial)

In a 12-week industry yoghurt trial (n=80), rooster comb extract raised affected-knee strength readouts (peak torque, work, power) by at least 11% in men, with no effect in women. This is a sex-limited knee-function signal from a single small trial, not a general muscle-building or recovery effect.

May support synovial fluid composition

High-molecular-weight hyaluronic acid is a core component of healthy synovial fluid; oral delivery is theorized to support synovial fluid composition and joint lubrication, complementing the broader rooster comb extract polysaccharide profile.

Modulates joint-health-related gene expression

A peripheral blood transcriptomics study of oral rooster comb extract rich in hyaluronic acid reported shifts in gene expression patterns related to articular health, supporting a measurable biological response to oral supplementation.

Mechanism of action

1

High-molecular-weight hyaluronic acid signalling

High-molecular-weight hyaluronic acid is associated with anti-inflammatory effects via CD44 receptor engagement and may modulate macrophage activity in joint tissue, providing a mechanistic basis for the joint-comfort effects observed in Mobilee® trials.

2

Polysaccharide and collagen-stimulating fraction

Mobilee® combines hyaluronic acid with additional polysaccharides and a collagen-stimulating fraction, theorized to support extracellular matrix integrity and collagen synthesis in connective tissue beyond a hyaluronic-acid-only profile.

3

Gut-mediated signalling and absorption

Oral hyaluronic acid is primarily broken down in the gastrointestinal tract; bioactivity is thought to arise from gut-associated immune and signalling pathways and from absorbed low-molecular-weight fragments, rather than direct intact systemic delivery.

Clinical trials

1
Mobilee® Rooster Comb Extract Yoghurt RCT for Knee Function (Solá et al. 2015)
PubMed

Randomized, double-blind, parallel, placebo-controlled trial of a low-fat yoghurt supplemented with rooster comb extract rich in hyaluronic acid (delivering ~80 mg/day Mobilee®) vs placebo yoghurt in adults with mild knee pain over 12 weeks. Outcomes: muscle strength indicators, knee pain, function.

Adults with mild knee pain; 12-week intervention via fortified yoghurt.

Yoghurt fortified with rooster comb extract raised affected-knee strength readouts (peak torque, work, power) by at least 11% in men, with no effect in women; the report does not show a separate knee-pain reduction. Industry (Bioiberica) trial; food-matrix delivery, sex-limited effect and small size are important caveats.

2
Rooster Comb Extract Yoghurt RCT with Transcriptomics Substudy (Sánchez et al. 2014)
PubMed

Randomized, double-blind, placebo-controlled clinical trial assessing peripheral blood transcriptomics in adults supplemented with rooster comb extract rich in hyaluronic acid (Mobilee® formulation). Aim: identify potential biomarkers of articular health improvement.

Adults with joint discomfort (68 completers, 34 per group) in a 90-day yoghurt study; blood-microarray substudy in 20 subjects.

90-day yoghurt RCT of rooster comb extract (Mobilee, 65% hyaluronic acid); 68 completed, 34 per group. Supplementation reduced articular pain intensity and synovial effusion and improved knee muscular strength indicators versus placebo. A blood-microarray substudy in 20 subjects found about 157 differentially expressed genes proposed as joint-health biomarkers. Industry (Bioiberica) trial delivered in a yoghurt matrix.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated in published 12-week trials.
Mild gastrointestinal discomfort possible at start of use.
Avoid in individuals with known allergy to poultry or rooster comb derivatives.
Limited long-term safety data beyond 12-week trial durations.
Not extensively studied in pregnancy, lactation, or pediatric populations.

Important Drug interactions

Anti-inflammatory medications (NSAIDs, corticosteroids) — overlapping joint-comfort effects; not contraindicated but consider dose adjustment with clinician.
Anticoagulants (warfarin, DOACs) — no specific interaction documented but joint-pain supplements warrant clinician oversight.
Intra-articular hyaluronic acid injections — overlapping joint-targeted intent; discuss combined use with clinician.
Other oral joint supplements (glucosamine, chondroitin, type II collagen) — overlapping intent; combining is common but track response.

Frequently asked questions about Mobilee® (High-Molecular-Weight Oral Hyaluronic Acid Complex)

What is Mobilee?

Mobilee® is a Bioiberica-developed oral joint-health ingredient combining high-molecular-weight hyaluronic acid (≈60-70%) with polysaccharides and a collagen-stimulating fraction, derived from rooster comb extract.

What is Mobilee used for?

Mobilee is researched primarily for Joint Health and Muscle & Recovery. A 90-day industry RCT (68 completers) reported reduced knee pain intensity and synovial effusion versus placebo yoghurt. The separate 12-week trial measured knee muscle strength, not pain.

What is the recommended dosage of Mobilee?

The clinically studied dose is ~80 mg/day rooster comb extract (about 50 mg hyaluronic acid/day) for 12 weeks (Sola) and 90 days (Sanchez); both cited trials delivered it in a low-fat yoghurt. Always follow the product label and check with a healthcare provider for personal advice.

Is Mobilee safe, and does it have side effects?

For most healthy adults, Mobilee is well tolerated at studied doses. Reported effects can include: Generally well tolerated in published 12-week trials. Mild gastrointestinal discomfort possible at start of use. It may also interact with some medications. Mobilee is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Mobilee interact with any medications?

Possible interactions include: Anti-inflammatory medications (NSAIDs, corticosteroids) — overlapping joint-comfort effects; not contraindicated but consider dose adjustment with clinician. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Mobilee?

NutraSmarts rates the evidence for Mobilee as Moderate (3 out of 5). It is backed by 2 clinical trials and 2 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Solà R, Valls RM, Martorell I, Giralt M, Pedret A, Taltavull N, Romeu M, Rodríguez Á, Moriña D, Lopez de Frutos V, Montero M, Casajuana MC, Pérez L, Faba J, Bernal G, Astilleros A, González R, Puiggrós F, Arola L, Chetrit C, Martinez-Puig D. A low-fat yoghurt supplemented with a rooster comb extract on muscle joint function in adults with mild knee pain: a randomized, double blind, parallel, placebo-controlled, clinical trial of efficacy. Food Funct. 2015;6(11):3531-9. doi: 10.1039/c5fo00321k.PubMedUsed to support: 12-week RCT in adults with mild knee pain (n=80) of a low-fat yoghurt fortified with rooster comb extract (80 mg/day, Mobilee) versus placebo yoghurt. Affected-knee muscle strength by isokinetic dynamometer (peak torque, total work, mean power at 180 deg/s) rose at least 11% in men (p<0.05), with no effect in women. This trial did not report a knee-pain outcome. Industry (Bioiberica) authors and yoghurt food-matrix delivery are key caveats.
  2. Sánchez J, Bonet ML, Keijer J, van Schothorst EM, Möller I, Chetrit C, Martinez-Puig D, Palou A. Blood cells transcriptomics as source of potential biomarkers of articular health improvement: effects of oral intake of a rooster combs extract rich in hyaluronic acid. Genes Nutr. 2014;9(5):417. doi: 10.1007/s12263-014-0417-3.PubMedUsed to support: 90-day RCT: adults with joint discomfort ate placebo yoghurt or yoghurt with rooster comb extract (65% hyaluronic acid, Mobilee); 68 completed, 34 per group. Supplementation reduced articular pain intensity and synovial effusion and improved knee muscular strength indicators versus placebo. A whole-genome blood-microarray substudy in 20 subjects found about 157 differentially expressed genes, proposed as candidate joint-health biomarkers. Industry (Bioiberica) authors and yoghurt delivery are key caveats.